{"id":"NCT01827046","sponsor":"Johns Hopkins University","briefTitle":"Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III","officialTitle":"Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12-30","primaryCompletion":"2018-09","completion":"2018-09","firstPosted":"2013-04-09","resultsPosted":"2019-09-27","lastUpdate":"2019-09-27"},"enrollment":499,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Intracerebral Hemorrhage"],"interventions":[{"type":"DRUG","name":"rt-PA","otherNames":["Activase","Alteplase","CathFlo"]}],"arms":[{"label":"MIS plus rt-PA management","type":"EXPERIMENTAL"},{"label":"Medical management","type":"NO_INTERVENTION"}],"summary":"A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).","primaryOutcome":{"measure":"Dichotomized, Adjudicated Modified Rankin Scale Score 0-3 vs. 4-6 at 365 Days Post Ictus (Adjusted)","timeFrame":"Day 365","effectByArm":[{"arm":"MIS Plus Rt-PA Management","deltaMin":110,"sd":null},{"arm":"Medical Management","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.73"},{"comp":"OG000 vs OG001","p":"0.33"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":25},"locations":{"siteCount":84,"countries":["United States","Australia","Canada","China","Germany","Hungary","Israel","Spain","United Kingdom"]},"refs":{"pmids":["40250866","38670789","37684058","34937780","30739747"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":75,"n":250},"commonTop":["Nervous system disorders","Respiratory, thoracic and mediastinal disorders","Infections, non-neurologic","General disorders and administration site conditions","Vascular disorders"]}}